![]() |
|
|
Vol. 297, Issue 1, 437-445, April 2001
Unidad "Carlos Méndez" del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Colima, México (J.A.S.-C., D.E.B.-H., R.N.-P.); and Instituto de Fisiología de la Benemérita Universidad Autónoma de Puebla, Puebla, México (E.S.-S., J.T.-J.)
| |
Abstract |
|---|
|
|
|---|
The effects of the antimalarial drug chloroquine on cardiac action potential and membrane currents were studied at clinically relevant concentrations. In cat Purkinje fibers, chloroquine at concentrations of 0.3 to 10 µM increased action potential duration, and reduced maximum upstroke velocity. At concentrations of 3 and 10 µM, chloroquine increased automaticity and reduced maximum diastolic potential, and after 60 min of perfusion with a concentration 10 µM, spontaneous activity was abolished. In isolated cat ventricular myocytes, chloroquine also increased action potential duration in a concentration-dependent manner, and reduced resting membrane potential at 3 and 10 µM. In voltage-clamped cat ventricular myocytes, chloroquine blocked several inward and outward membrane currents. The order of potency was inward rectifying potassium current (IK1) > rapid delayed rectifying potassium current (IKr) > sodium current (INa) > L-type calcium current (ICa-L). Only tonic block of INa and ICa-L was observed at a stimulation frequency of 0.1 Hz and no additional blockade was observed during stimulation trains applied at 1 Hz. The effect of chloroquine on IK1 was voltage-dependent, with less pronounced blockade at negative test potentials. In addition, unblock was achieved by hyperpolarizing pulses to potentials negative to the current reversal potential. Chloroquine blocked the rapid component of the delayed rectifying outward current, IKr, but not the slow component, IKs. These findings provide the cellular mechanisms for the prolonged QT interval, impaired ventricular conduction, and increased automaticity induced by chloroquine, which have been suggested as responsible for the proarrhythmic effects of the drug.
| |
Introduction |
|---|
|
|
|---|
Malaria
remains one of the most important and widespread diseases in the world.
Chloroquine is one of the drugs of first choice for treatment of
malaria. Chloroquine is also used as an anti-inflammatory agent in
rheumatoid arthritis and in lupus erythematosus (Webster, 1992
).
However, the use of chloroquine has been associated with toxic
cardiovascular effects, including a fall in blood pressure (Olatunde,
1970
) and rhythm abnormalities (Williams, 1966
; Guedira et al., 1998
).
Prolonged therapy can lead to cardiac failure (Hughes et al., 1971
) and
electrocardiographic changes, including T-wave depression or inversion,
and prolonged QRS and QTc intervals (Sanghvi and Mathur, 1965
;
Bustos et al., 1994
). Chloroquine has also been reported to induce
torsade de pointes (Harris et al., 1988
; Fauchier et al., 1993
), a
tachyarrhythmia associated with medications that block repolarizing
cardiac K+ currents. Acute poisoning by
chloroquine can cause death by failure of myocardial contraction and
cardiac arrest (Don-Michael and Aiwazzadeh, 1970
).
The proarrhythmic effects of chloroquine are well documented; however,
there are only two published studies describing the cellular
electrophysiological effects of this drug. Harris et al. (1988)
used
microelectrode techniques and multicellular preparations (sheep
ventricular muscle and Purkinje fibers) to demonstrate that 5 to 50 µM chloroquine produced significant reduction in the maximum upstroke
velocity (Vmax) of the action
potential, an indirect measure of peak sodium channel conductance.
Harris et al. (1988)
also demonstrated that chloroquine prolonged
action potential duration and refractory period, effects usually
attributed to block of K+ currents. Recently,
Benavides-Haro and Sanchez-Chapula (2000)
demonstrated that chloroquine
blocked inward rectifier current (IK1) and the
acetylcholine K+ current,
IK(Ach), in guinea pig atrial and
ventricular myocytes.
A slowing in ventricular conduction and an excessive lengthening in the
QT interval have been proposed as the mechanisms of the proarrhythmic
effects of chloroquine (Harris et al., 1988
; Bustos et al., 1994
;
Guedira et al., 1998
). Blockade of inward sodium current
(INa) has been suggested as the principal cause of impaired ventricular conduction, and acquired long QT syndrome is
usually caused by blockade of one or more potassium currents (Nattel,
1998
). In the present study, we investigated the effects of chloroquine
on action potentials and the major ionic currents contributing to the
shape of the action potential in isolated feline ventricular myocytes.
Chloroquine lengthened action potentials of cat Purkinje fibers, and
increased automaticity. Standard voltage-clamp techniques were used to
record INa and L-type calcium current (ICa-L), and four potassium currents, including
the IK1, the transient outward current
(Ito), and the rapid and slow delayed rectifier outward currents (IKr and
IKs). Chloroquine blocked four of these currents:
IK1, IKr,
INa, and ICa-L. These
findings provide the cellular mechanism for the prolonged action
potentials and reduction in Vmax of
cardiac action potentials previously reported by Harris et al. (1988)
,
and insights into the mechanism of induction of arrhythmias.
| |
Materials and Methods |
|---|
|
|
|---|
Standard Microelectrode Technique.
Adult cats (2-4 kg) were
anesthetized with sodium pentobarbital (35 mg/kg) and heparinized (1000 U/kg). Free-running Purkinje strands were obtained from the left
ventricle of the cat hearts. The Purkinje strands were fixed to the
Sylgard (Dow Corning Co., Midland, MI)-coated bottom of a Plexiglas
chamber (2-ml volume) with micropins. The preparations were superfused
with a solution containing 125 mM NaCl, 24 mM
NaHCO3, 0.43 mM
NaH2PO4, 4 mM KCl, 1.8 mM
CaCl2, 1.05 mM MgCl2, and
11 mM glucose. The solution was equilibrated with 95%
O2, 5% CO2 (pH 7.4).
Temperature was kept constant at 35°C. The preparations were allowed
to equilibrate for 60 min before experimental protocols were performed.
During this time the preparations were stimulated at a frequency of 1 Hz with rectangular stimuli (3-ms duration, 1.5 times diastolic threshold intensity) delivered by insulated (except at the tips) silver
bipolar electrodes. Action potentials were recorded by using glass
microelectrodes filled with 3 M KCl (resistance 10-15 M
) coupled to
the input of a high-impedance preamplifier (World Precision
Instruments, New Haven, CT). Action potential signals were digitized at
a sampling rate of 10 kHz by use of an analog-to-digital converter
(Digidata 1200 interface; Axon Instruments, Burlingame, CA) and stored
on a hard disk, Axotape data-acquisition software (Axon Instruments),
and a 486DX2 computer. Data analysis was performed using pClamp
software (version 6.0.4; Axon Instruments). We have performed
experiments recording action potentials in Purkinje fibers for up to
8 h under control conditions. We have not observed significant
changes in action potential parameters or spontaneous firing frequency.
Cell Preparation.
Single ventricular myocytes were obtained
from the right ventricular free wall of adult cats as previously
described (Sanchez-Chapula, 1996
). The hearts were mounted on a
Langendorff apparatus and perfused for 5 min with normal Tyrode's
solution, and then switched to a nominally calcium-free solution for an
additional 5 min. Afterward, the hearts were perfused for 30 min with a
zero-calcium solution containing 1 mg/ml type I collagenase (Sigma
Chemical Co., St. Louis, MO) and 0.05 mg/ml protease XIV (Sigma
Chemical Co.). The enzymes were washed out by perfusion with a
high-potassium, low-chloride saline (KB medium; Isenberg and
Klöckner, 1982
) for 5 min. The free wall of the right ventricle
was dissected away from the rest of the heart and cut into small
pieces. Single cells were maintained in a high-potassium, low-chloride
solution at 4°C for up to 10 h before use in
electrophysiological experiments.
Electrical Recordings.
A few drops of the cell suspension
were placed in a chamber (0.5-ml volume) mounted on a modified stage of
an inverted microscope (Nikon Diaphot, Tokyo, Japan). The chamber was
superfused at a rate of 0.5 ml/min with normal external solution.
Action potential experiments in isolated ventricular myocytes were
performed at 35°C, using the whole-cell "perforated patch"
current clamp technique. Sodium, calcium, and potassium currents were
recorded using the whole-cell standard patch-clamp method
(Hamill et al., 1981
) and an Axopatch 1C patch-clamp amplifier (Axon
Instruments). A Labmaster-TL/1 interface (Axon Instruments) controlled
by pClamp 6.0.3 software (Axon Instruments) was used to generate
voltage-clamp command protocols and acquire data. Currents were
filtered at 2 kHz with a four-pole Bessel filter, digitally sampled at
4 kHz and stored on the hard disk of an Epson 486Dx/33 computer.
IK currents were recorded at a sampling frequency
of 2 KHz and filtered at 1 KHz. Micropipettes were pulled from
borosilicate glass capillary tubes (TW 150-6; World Precision
Instruments, Inc., Sarasota, FL) on a programmable horizontal puller
(Sutter Instruments, Novato, CA). When filled with the intracellular
solution, the pipette tip resistance was 1 to 2 M
. Series resistance
compensation was set to 80%, and whole-cell capacitance compensation
was optimized to minimize capacitive currents and reduce voltage
errors. We only analyzed experiments in which access resistance was
1.2 M
after compensation. The experiments to determine the effect of chloroquine on INa were performed at a
temperature of 15°C. Recordings of calcium and potassium currents
were performed at 35°C.
Solutions. Tyrode's solution had the following composition: 125 mM NaCl, 24 mM NaHCO3, 0.42 mM NaH2PO4, 5.4 mM KCl, 1.8 mM CaCl2, 1.05 mM MgCl2, 11 mM glucose, and 10 mM taurine. The solution was equilibrated with 95% O2,5% CO2, pH 7.4. Nominally, calcium-free solution was prepared by omitting CaCl2 from the Tyrode's solution. The high-potassium, low-chloride solution (KB medium) had the following composition: 80 mM potassium glutamate, 50 mM KCl, 20 mM taurine, 3 mM KH2PO4, 10 mM glucose, 10 mM HEPES, and 0.2 mM EGTA. The pH was adjusted to 7.4 with KOH.
The normal external solution used to record action potentials in isolated ventricular myocytes had the following composition: 140 mM NaCl, 4 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 10 mM HEPES, and 11 mM glucose, pH adjusted to 7.4 with NaOH. The pipette solution had the following composition: 90 mM potassium aspartate, 45 mM KCl, 10 mM KH2PO4, 5 mM HEPES, and 200 µg/ml nystatin, pH 7.3 with KOH. For measuring INa, the external solution contained 10 mM NaCl, 120 mM CsCl, 0.5 mM CaCl2, 2 mM CoCl2, 1 mM MgCl2, 10 mM HEPES, and 11 mM glucose; pH was adjusted to 7.4 with CsOH. The pipette solution was composed of 132 mM CsCl, 8 mM NaCl, 5 mM MgATP, 5 mM HEPES, and 5 mM EGTA; pH was adjusted to 7.3 with CsOH. For measuring ICa-L, the external solution contained 140 mM tetraethylammonium chloride, 4 mM CsCl, 3.6 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 11mM glucose; pH was adjusted to 7.4 with tetraethylammonium hydroxide. The internal solution had the following composition: 140 mM CsCl, 5 mM MgATP, 5 mM HEPES, and 5 mM EGTA; pH was adjusted to 7.3 with KOH. The calcium-cobalt external solution used to record potassium currents had the following composition: 140 mM NaCl, 4 mM KCl, 0.1 mM CaCl2, 0.5 mM CoCl2, 1 mM MgCl2, 10 mM HEPES, and 11 mM glucose; pH was adjusted to 7.4 with NaOH. The internal (pipette filling) solution had the following composition: 80 mM potassium aspartate, 40 mM KCl, 10 mM KH2PO4, 1 mM MgSO4, 5 mM Na2ATP, 5 mM HEPES, and 5 mM EGTA; pH was adjusted to 7.3 with KOH. Chloroquine-HCl (Sigma Chemical Co.) was directly dissolved in the different external solution at the desired concentration. MK-499 (kindly provided by Dr. J. J. Lynch, Jr., Merck & Co., Inc., West Point, PA) was dissolved in dimethyl sulfoxide as a 0.1 M stock solution. Nystatin was dissolved in dimethyl sulfoxide at a concentration of 25 mg/ml.Statistics. Data are expressed as means ± S.E.M. Statistical significance was evaluated by ANOVA and Dunnett's t test. Differences were considered significant at P < 0.05.
| |
Results |
|---|
|
|
|---|
Effects of Chloroquine on Action Potentials.
Chloroquine
increased action potential duration and decreased
Vmax) in a concentration-dependent
(0.3-10 µM) manner in cat Purkinje fibers stimulated at a basic
cycle length (BCL) of 1000 ms (Fig.
1A; Table 1). In
addition, at concentrations of 3 and 10 µM, chloroquine decreased the
maximum diastolic potential. Action potentials in ventricular myocytes
were elicited by 5-ms pulses applied at a basic cycle length of 1000 ms, using the whole-cell perforated patch-clamp technique.
Chloroquine at concentrations 1 to 10 µM increased action potential
duration (APD) in a concentration-dependent manner (Fig. 1B; Table 1).
At concentrations 3 and 10 µM, it decreased resting membrane
potential, action potential peak, and plateau amplitudes (Fig. 1B;
Table 1).
|
|
46 ± 3 mV. Chloroquine did not induce
afterdepolarizations at any of the concentrations used
(n = 5).
|
Effects of Chloroquine on INa.
To improve voltage
control, the experiments were performed at 15°C using a low-sodium
external solution (under Materials and Methods). In
patch-clamp experiments, the voltage dependence of INa activation and inactivation slowly drifts
toward more negative potentials during the first 10 min after rupture
of the membrane patch (Kimitsuki et al., 1990
). In the present study,
control INa recordings were initiated at least 15 min after the rupture of the membrane patch. To test the effects of
chloroquine (0.3-10 µM) on INa, 40-ms
depolarizing pulses were applied from a holding potential of
120 mV
to membrane potentials ranging from
80 to +10 mV at a frequency of
0.1 Hz. Only a single concentration of chloroquine was tested in each
myocyte. Chloroquine decreased peak current amplitude at all potentials
studied (Fig. 3A). The drug did not
change the threshold potential, the potential at which peak
INa was maximum or the apparent reversal
potential (Fig. 3B). The percentage block of INa
peak amplitude was concentration-dependent. The concentration-dependent
effect of the drug on peak current, measured at
40 mV, is shown in
Table 2. The effects of chloroquine on
INa at concentrations of 0.3 to 3 µM were
completely reversible after washout, whereas at 10 µM the
reversibility was about 80% (data not shown). A possible additional
effect of chloroquine on INa at a stimulation
frequency (1 Hz) closer to the physiological range was studied by
applying trains of 20-ms pulses from a holding potential of
120 mV to
a test potential of
20 mV. No significant use-dependent effects were
observed (data not shown).
|
|
Effects of Chloroquine on ICa-L
The experiments on
calcium and potassium currents were performed at 35°C. The effect of
chloroquine on ICa-L was studied by applying depolarizing
pulses to membrane potentials ranging from
40 to +40 mV from a
holding potential of
70 mV. Pulses were applied at a frequency of 0.1 Hz. Chloroquine at 10 µM decreased the peak amplitude of
ICa-L measured at +10 mV by 32 ± 11%
(n = 5) (Fig. 4). The
drug did not alter the shape of the ICa-L-V relationship
(Fig. 4). The effect of chloroquine on ICa-L at a test
potential of +10 mV was concentration-dependent (Table 2). Each myocyte
was treated with a single concentration of chloroquine. The effects of
chloroquine at all concentrations used were partially reversible on
washout, about 60% after 1 and 3 µM and about 40% after 10 µM
(data not shown). Possible use-dependent block of ICa-L by
chloroquine was studied using a 1-Hz train of 200-ms pulses to +10 mV,
applied from a holding potential of
70 mV. No additional significant
use-dependent effects were observed (data not shown).
|
Effects of Chloroquine on Potassium Currents.
IK1 was elicited with hyperpolarizing and
depolarizing pulses of 500-ms duration to membrane potentials ranging
from
100 to
40 mV from a holding potential of
60 mV. Figure
5A shows current traces obtained under
control conditions and in the presence of 3 µM chloroquine. The
effect of chloroquine on IK1 measured at the end
of the pulses is shown in Fig. 5B. Chloroquine at 3 µM significantly
decreased current amplitude in a voltage-dependent manner.
IK1 measured at
40 mV was decreased by 94%, at
60 mV by 86%, and at
100 mV by 67%. In addition, during
hyperpolarizing pulses to membrane potentials of
90 and
100 mV, a
time-dependent unblock was observed (Fig. 5A, bottom). Table 2 shows
the concentration-dependent block by chloroquine. The effects of
chloroquine on IK1 at all concentrations used
were completely reversible on washout (data not shown).
|
30 to +50 mV from a holding
potential of
60 mV (Fig. 6A). Chloroquine did not
significantly affect the peak current amplitude or time course of
Ito. Peak current-voltage relationships are shown
in Fig. 6B. Possible use-dependent effects on Ito
were studied by applying 2-Hz trains of 200-ms pulses to +50 mV from a
holding potential of
60 mV. Chloroquine did not change
Ito peak amplitude during the train of pulses
(data not shown).
|
30 to +50 mV, applied from a holding potential of
40
mV. Tail currents were recorded upon repolarization to
40 mV (Fig.
7A). Chloroquine at 3 µM decreased the
holding current and the instantaneous current elicited by pulses to
30 and
10 mV, an effect likely caused by blockade of
IK1 or nondeactivated IKr.
In addition, chloroquine produced a decrease in the amplitude of the
time-dependent current, more pronounced at membrane potentials negative
to +20 mV (Fig. 7B), and decreased tail current amplitude (Fig. 7C). In
the presence of the drug, the I-V relationship of the time-dependent
current showed less inward rectification than control. The effects of chloroquine were 95% reversible after washout (data not shown).
|
30 mV and reached
saturation at +20 mV. The activation curve had a
V1/2 of
9.5 ± 1.2 mV and a
slope factor of 7.1 ± 0.9 mV. These values are similar to those
found for the dofetilide-sensitive current in cat ventricular myocytes
(Barajas-Martinez et al., 2000
|
|
| |
Discussion |
|---|
|
|
|---|
We found that chloroquine (0.3-10 µM) induced a decrease of
Vmax, prolonged APD, and decreased
maximum diastolic potential in cat isolated Purkinje fibers and
ventricular myocytes. Chloroquine also increased the firing frequency
of spontaneous activity in cat Purkinje fibers. In addition, after 60 min of superfusion with a concentration 10 µM, in four of five cat
Purkinje fibers spontaneous firing was abolished. In experiments under
voltage-clamp conditions, chloroquine inhibited
IK1 > IKr > INa > ICa-L. The transient
outward potassium current, Ito, and the slow
component of IK were not modified by chloroquine.
The blocking effects of chloroquine on IK1 were
significantly voltage-dependent, the block increased with
depolarization and decreased with hyperpolarization. This profile of
voltage dependence is consistent with a positively charged molecule
blocking the channel from the intracellular side and entering the pore
to such an extent as to be subjected to the transmembrane electrical
field (Snyders et al., 1992
; Benavides-Haro and Sanchez-Chapula, 2000
).
Chloroquine administered at therapeutic concentrations reaches plasma
concentrations of 0.29 to 0.48 µM (Webster, 1992
). In a retrospective
study of patients with acute chloroquine overdose, the mean amount
ingested by 167 patients was 4.5 ± 2.8 g. The mean blood
chloroquine concentration on admission was 20.5 ± 13.4 µM
(Clemessy et al., 1996
). Riou et al. (1988)
found in severe chloroquine
poisoning, blood levels ranging from 40 to 80 µM. Therefore, the
concentrations used in the present study are clinically relevant.
Chloroquine, administered at therapeutic concentrations, has been found
to produce different cardiovascular effects such as fall in blood
pressure, slowing of ventricular conduction, and electrocardiographic
changes such as lengthening of QRS and QT intervals (Bustos et al.,
1994
). Acute poisoning with chloroquine has been reported to produce
cardiac failure, rhythm disturbances, atrioventricular block (Guedira
et al., 1994
), impaired intraventricular conduction, and cardiac arrest
(Taboulet and Bismuth, 1994
).
To investigate the possible cellular electrophysiological mechanisms
responsible of the slowing in ventricular conduction, electrocardiographic changes, and rhythm disturbances, the effects of
chloroquine on action potential and the main ionic currents underlying
the ventricular action potential were studied. Using microelectrode
techniques in multicellular preparations, it was reported that
chloroquine depresses the action potential
Vmax, suggesting that the drug
inhibits INa (Harris et al., 1988
). In the
present work, we confirmed this assumption by showing that chloroquine
at concentrations of 1 µM and higher inhibited
INa. Class I antiarrhythmic drugs can be
proarrhythmic due to facilitation of re-entrant arrhythmias caused by
excessive slowing of conduction (Winkle et al., 1981
; Rinkenberger et
al., 1982
; Morganroth and Horowitz, 1984
). These proarrhythmic effects
are more frequent in association with coronary artery disease
(Morganroth, 1987
). The excessive slowing of conduction induced by
chloroquine due to inhibition of INa can be
worsened by the decrease of the diastolic membrane potential, which can
increase the fraction of inactivated sodium channels.
Chloroquine has also been found to produce hypotension, an effect
attributed to depression of cardiac contractility on the basis of the
observation that systolic blood pressure fell before diastolic pressure
(Olatunde, 1970
). Chloroquine in dogs produces significant reductions
in cardiac contractility and vascular resistance (Sofola, 1980
). In the
present work, we found that chloroquine at concentrations of 1 µM and
higher inhibited ICa-L. This effect can at least
partially explain the depression in cardiac contractility induced by
the drug. In addition, during acute chloroquine poisoning, third degree
atrioventricular block (Verny et al., 1992
; Guedira et al., 1998
) and
cardiac arrest (Clemessy et al., 1996
) have been reported. These
effects may also be explained by the inhibition of
ICa-L and INa.
In addition to the impaired intraventricular conduction and the
excessive lengthening in QT interval as a possible mechanism responsible for the proarrhythmic effects of chloroquine, the increase
in automaticity induced by the drug can also be a potential cause of
arrhythmias. The decrease in diastolic membrane potential and increase
in automaticity induced by chloroquine can be explained by its blocking
effects on IK1. During phase 4 of the Purkinje fibers action potential, slow depolarization results from activation of
the pacemaker current (If) (DiFrancesco and
Noble, 1985
). Because the maximum diastolic potential is near
90 mV,
the decay of the delayed rectifying outward current contributes only a
very small current during phase 4. On the other hand,
IK1 carries a very significant outward current
during the pacemaker depolarization, which largely balances the inward
current carried by If channels. For this reason,
factors that change IK1 have a large effect on Purkinje fiber rhythm and the maximum diastolic potential (Noble, 1995
). However, a direct effect of chloroquine on
If or electrogenic exchangers and pumps such as
Na+/K+ pump cannot be discounted.
The most frequent cardiovascular manifestations during chloroquine
treatment are the electrocardiographic changes, diminution of the T
wave, and prolongation of the QTc interval (Bustos et al., 1994
;
Bouree, 1997
). These effects can be explained by the action potential
duration increase induced by the drug. Clinical and animal data support
the hypothesis that acquired forms of long QT syndrome result from
prolonged repolarization that leads to early afterdepolarizations and
triggered arrhythmias (Surawicz, 1989
). Early afterdepolarizations can
be induced by block of potassium currents such as
IK1 or IKr (Kaseda et al.,
1989
), by activation of L-type Ca2+ current
(January and Riddle, 1989
), or inhibition of Na+
current inactivation (Boutjdir and El-Sherif, 1991
). The most common
mechanism of drug-induced torsades de pointes is
IKr inhibition. In our experiments, chloroquine
did not induce early afterdepolarizations; however, under voltage-clamp
conditions, the most prominent effect of chloroquine on cardiac
membrane currents was a marked reduction of IK1
and IKr. The marked reduction of both
IK1 and IKr can explain the
prolongation of action potential duration induced by the drug (Harris
et al., 1988
). On the other hand, the reduction of
INa and ICa-L induced by
chloroquine may limit the prolongation of action potential duration and
the appearance of afterdepolarizations.
In conclusion, we have found that the antimalarial drug chloroquine at clinically relevant concentrations inhibited several currents in cat ventricular myocytes. These effects can explain most of the electrophysiological modifications and proarrhythmic effects reported for chloroquine in mammalian cardiac preparations.
| |
Acknowledgments |
|---|
We thank Dr. Michael Sanguinetti for critical reading of the manuscript, and Olivia Mercado Ruiz for technical assistance and preparation of the figures.
| |
Footnotes |
|---|
Accepted for publication December 13, 2000.
Received for publication September 15, 2000.
This work was partially supported by National Institutes of Health Fogarty Grant (R03-TW01211), Consejo Nacional de Ciencia y Tecnologia (México) Grant 34954-M, and Fondo Ramon Alvarez-Buylla (Universidad de Colima, México).
Send reprint requests to: José A. Sánchez-Chapula, M.D., Ph.D., CUIB, Universidad de Colima, Apdo. Postal 199, C.P. 28000, Colima, Col. México. E-mail: sancheza{at}cgic.ucol.mx
| |
Abbreviations |
|---|
Vmax, maximum upstroke velocity; IK1, inward rectifying potassium current; INa, sodium current; ICa-L, type L calcium current; Ito, transient outward potassium current; IKr, rapid delayed rectifying potassium current; IKs, slow delayed rectifying potassium current; APD, action potential duration; If, pacemaker current.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. A. Rodriguez-Menchaca, R. A. Navarro-Polanco, T. Ferrer-Villada, J. Rupp, F. B. Sachse, M. Tristani-Firouzi, and J. A. Sanchez-Chapula The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel PNAS, January 29, 2008; 105(4): 1364 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, D. W. Benson, M. Tristani-Firouzi, L. J. Ptacek, R. Tawil, P. J. Schwartz, A. L. George, M. Horie, G. Andelfinger, G. L. Snow, et al. Electrocardiographic Features in Andersen-Tawil Syndrome Patients With KCNJ2 Mutations: Characteristic T-U-Wave Patterns Predict the KCNJ2 Genotype Circulation, May 31, 2005; 111(21): 2720 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon Pharmacology of cardiac potassium channels Cardiovasc Res, April 1, 2004; 62(1): 9 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Sanchez-Chapula, T. Ferrer, R. A. Navarro-Polanco, and M. C. Sanguinetti Voltage-Dependent Profile of Human Ether-a-go-go-Related Gene Channel Block Is Influenced by a Single Residue in the S6 Transmembrane Domain Mol. Pharmacol., May 1, 2003; 63(5): 1051 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Sanchez-Chapula, R. A. Navarro-Polanco, C. Culberson, J. Chen, and M. C. Sanguinetti Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block J. Biol. Chem., June 21, 2002; 277(26): 23587 - 23595. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||